Cargando…

High Human T Cell Leukemia Virus Type-1(HTLV-1) Provirus Load in Patients with HTLV-1 Carriers Complicated with HTLV-1-unrelated disorders

BACKGROUND: To address the clinical and virological significance of a high HTLV-1 proviral load (VL) in practical blood samples from asymptomatic and symptomatic carriers, we simultaneously examined VL and clonal expansion status using polymerase chain reaction (PCR) quantification (infected cell %...

Descripción completa

Detalles Bibliográficos
Autores principales: Sasaki, Daisuke, Doi, Yuko, Hasegawa, Hiroo, Yanagihara, Katsunori, Tsukasaki, Kunihiro, Iwanaga, Masako, Yamada, Yasuaki, Watanabe, Toshiki, Kamihira, Shimeru
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2876101/
https://www.ncbi.nlm.nih.gov/pubmed/20423527
http://dx.doi.org/10.1186/1743-422X-7-81
_version_ 1782181661377560576
author Sasaki, Daisuke
Doi, Yuko
Hasegawa, Hiroo
Yanagihara, Katsunori
Tsukasaki, Kunihiro
Iwanaga, Masako
Yamada, Yasuaki
Watanabe, Toshiki
Kamihira, Shimeru
author_facet Sasaki, Daisuke
Doi, Yuko
Hasegawa, Hiroo
Yanagihara, Katsunori
Tsukasaki, Kunihiro
Iwanaga, Masako
Yamada, Yasuaki
Watanabe, Toshiki
Kamihira, Shimeru
author_sort Sasaki, Daisuke
collection PubMed
description BACKGROUND: To address the clinical and virological significance of a high HTLV-1 proviral load (VL) in practical blood samples from asymptomatic and symptomatic carriers, we simultaneously examined VL and clonal expansion status using polymerase chain reaction (PCR) quantification (infected cell % of peripheral mononuclear cells) and Southern blotting hybridization (SBH) methods. RESULTS: The present study disclosed extremely high VL with highly dense smears with or without oligoclonal bands in SBH. A high VL of 10% or more was observed in 16 (43.2%) of a total of 33 samples (one of 13 asymptomatic carriers, 8 of 12 symptomatic carriers, and 7 of 8 patients with lymphoma-type ATL without circulating ATL cells). In particular, an extremely high VL of 50% or more was limited to symptomatic carriers whose band findings always contained at least dense smears derived from polyclonally expanded cells infected with HTLV-1. Sequential samples revealed that the VL value was synchronized with the presence or absence of dense smears, and declined at the same time as disappearing dense smears. Dense smears transiently emerged at the active stage of the underlying disease. After disappearance of the smears, several clonal bands became visible and were persistently retained, explaining the process by which the clonality of HTLV-1-infected cells is established. The cases with only oligoclonal bands tended to maintain a stable VL of around 20% for a long time. Two of such cases developed ATL 4 and 3.5 years later, suggesting that a high VL with oligoclonal bands may be a predisposing risk to ATL. CONCLUSION: The main contributor to extremely high VL seems to be transient emergence of dense smears detected by the sensitivity level of SBH, corresponding to polyclonal expansion of HTLV-1-infected cells including abundant small clones. Major clones retained after disappearance of dense smears stably persist and acquire various malignant characteristics step by step.
format Text
id pubmed-2876101
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-28761012010-05-26 High Human T Cell Leukemia Virus Type-1(HTLV-1) Provirus Load in Patients with HTLV-1 Carriers Complicated with HTLV-1-unrelated disorders Sasaki, Daisuke Doi, Yuko Hasegawa, Hiroo Yanagihara, Katsunori Tsukasaki, Kunihiro Iwanaga, Masako Yamada, Yasuaki Watanabe, Toshiki Kamihira, Shimeru Virol J Research BACKGROUND: To address the clinical and virological significance of a high HTLV-1 proviral load (VL) in practical blood samples from asymptomatic and symptomatic carriers, we simultaneously examined VL and clonal expansion status using polymerase chain reaction (PCR) quantification (infected cell % of peripheral mononuclear cells) and Southern blotting hybridization (SBH) methods. RESULTS: The present study disclosed extremely high VL with highly dense smears with or without oligoclonal bands in SBH. A high VL of 10% or more was observed in 16 (43.2%) of a total of 33 samples (one of 13 asymptomatic carriers, 8 of 12 symptomatic carriers, and 7 of 8 patients with lymphoma-type ATL without circulating ATL cells). In particular, an extremely high VL of 50% or more was limited to symptomatic carriers whose band findings always contained at least dense smears derived from polyclonally expanded cells infected with HTLV-1. Sequential samples revealed that the VL value was synchronized with the presence or absence of dense smears, and declined at the same time as disappearing dense smears. Dense smears transiently emerged at the active stage of the underlying disease. After disappearance of the smears, several clonal bands became visible and were persistently retained, explaining the process by which the clonality of HTLV-1-infected cells is established. The cases with only oligoclonal bands tended to maintain a stable VL of around 20% for a long time. Two of such cases developed ATL 4 and 3.5 years later, suggesting that a high VL with oligoclonal bands may be a predisposing risk to ATL. CONCLUSION: The main contributor to extremely high VL seems to be transient emergence of dense smears detected by the sensitivity level of SBH, corresponding to polyclonal expansion of HTLV-1-infected cells including abundant small clones. Major clones retained after disappearance of dense smears stably persist and acquire various malignant characteristics step by step. BioMed Central 2010-04-28 /pmc/articles/PMC2876101/ /pubmed/20423527 http://dx.doi.org/10.1186/1743-422X-7-81 Text en Copyright ©2010 Sasaki et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Sasaki, Daisuke
Doi, Yuko
Hasegawa, Hiroo
Yanagihara, Katsunori
Tsukasaki, Kunihiro
Iwanaga, Masako
Yamada, Yasuaki
Watanabe, Toshiki
Kamihira, Shimeru
High Human T Cell Leukemia Virus Type-1(HTLV-1) Provirus Load in Patients with HTLV-1 Carriers Complicated with HTLV-1-unrelated disorders
title High Human T Cell Leukemia Virus Type-1(HTLV-1) Provirus Load in Patients with HTLV-1 Carriers Complicated with HTLV-1-unrelated disorders
title_full High Human T Cell Leukemia Virus Type-1(HTLV-1) Provirus Load in Patients with HTLV-1 Carriers Complicated with HTLV-1-unrelated disorders
title_fullStr High Human T Cell Leukemia Virus Type-1(HTLV-1) Provirus Load in Patients with HTLV-1 Carriers Complicated with HTLV-1-unrelated disorders
title_full_unstemmed High Human T Cell Leukemia Virus Type-1(HTLV-1) Provirus Load in Patients with HTLV-1 Carriers Complicated with HTLV-1-unrelated disorders
title_short High Human T Cell Leukemia Virus Type-1(HTLV-1) Provirus Load in Patients with HTLV-1 Carriers Complicated with HTLV-1-unrelated disorders
title_sort high human t cell leukemia virus type-1(htlv-1) provirus load in patients with htlv-1 carriers complicated with htlv-1-unrelated disorders
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2876101/
https://www.ncbi.nlm.nih.gov/pubmed/20423527
http://dx.doi.org/10.1186/1743-422X-7-81
work_keys_str_mv AT sasakidaisuke highhumantcellleukemiavirustype1htlv1provirusloadinpatientswithhtlv1carrierscomplicatedwithhtlv1unrelateddisorders
AT doiyuko highhumantcellleukemiavirustype1htlv1provirusloadinpatientswithhtlv1carrierscomplicatedwithhtlv1unrelateddisorders
AT hasegawahiroo highhumantcellleukemiavirustype1htlv1provirusloadinpatientswithhtlv1carrierscomplicatedwithhtlv1unrelateddisorders
AT yanagiharakatsunori highhumantcellleukemiavirustype1htlv1provirusloadinpatientswithhtlv1carrierscomplicatedwithhtlv1unrelateddisorders
AT tsukasakikunihiro highhumantcellleukemiavirustype1htlv1provirusloadinpatientswithhtlv1carrierscomplicatedwithhtlv1unrelateddisorders
AT iwanagamasako highhumantcellleukemiavirustype1htlv1provirusloadinpatientswithhtlv1carrierscomplicatedwithhtlv1unrelateddisorders
AT yamadayasuaki highhumantcellleukemiavirustype1htlv1provirusloadinpatientswithhtlv1carrierscomplicatedwithhtlv1unrelateddisorders
AT watanabetoshiki highhumantcellleukemiavirustype1htlv1provirusloadinpatientswithhtlv1carrierscomplicatedwithhtlv1unrelateddisorders
AT kamihirashimeru highhumantcellleukemiavirustype1htlv1provirusloadinpatientswithhtlv1carrierscomplicatedwithhtlv1unrelateddisorders